Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...
The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...
The Food and Drug Administration said on Friday that the shortage of semaglutide injection products, such as Novo Nordisk's Wegovy, has been resolved. FDA's update led to renewed uncertainty for a ...
The shortage of semaglutide injections (Ozempic, Wegovy) is over, the FDA announced on Friday. The agency, along with maker Novo Nordisk, confirmed that supply now meets or exceeds both the current ...
Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...
It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...
22h
GlobalData on MSNZealand Pharma steadfastly upholds amylin-based obesity drug strategyZealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
27mOpinion
Hosted on MSNOn the Death of a Loved OneThere is a loss of words with the sudden death of a loved one. To say too little is offensive and somehow diminishes your ...
2d
Pharmaceutical Technology on MSNGLP-1RAs and opioid use disorder: a new frontier in addiction treatmentWhile medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...
Hims & Hers Health Inc. has acquired a California-based manufacturing facility to expand its range of peptide treatments, ...
The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results